Finance

Lists
300636:SHE
Jiangxi Synergy Pharmaceutical Co Ltd
CNÂ¥7.09
0.00%
(0.00) 1D
Sep 30, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300636...
Open
CNÂ¥7.09
High
CNÂ¥7.18
Low
CNÂ¥7.07
Mkt. cap
2.98B
Avg. vol.
5.33M
Volume
0.00
Dividend
0.56%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
76.02
52-wk high
CNÂ¥8.93
52-wk low
CNÂ¥6.11
EPS
CNÂ¥0.09
Shares outstanding
419.95M
No. of employees
2K
Open
CNÂ¥7.09
High
CNÂ¥7.18
Low
CNÂ¥7.07
Mkt. cap
2.98B
Avg. vol.
5.33M
Volume
0.00
Dividend
0.56%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
76.02
52-wk high
CNÂ¥8.93
52-wk low
CNÂ¥6.11
EPS
CNÂ¥0.09
Shares outstanding
419.95M
No. of employees
2K
News stories
From web sources and news partners
About Jiangxi Synergy Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedApr 20, 2004
Headquarters-
SectorPharmaceutical industry
Websitejxsynergy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
208.82M
192.42M
184.39M
198.77M
Cost of goods sold
120.66M
199.99M
131.75M
153.08M
Cost of revenue
120.66M
199.99M
131.75M
153.08M
Research and development expenses
14.39M
23.96M
15.51M
20.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.28M
19.11M
16.05M
19.29M
Operating expense
33.51M
44.05M
29.36M
45.75M
Total operating expenses
154.17M
244.04M
161.11M
198.83M
Operating income
54.65M
-51.62M
23.29M
-61.66K
Other non operating income
3.20M
-3.77M
-863.12K
513.50K
EBT including unusual items
27.84M
-16.84M
19.62M
961.86K
EBT excluding unusual items
56.95M
-51.51M
20.10M
-2.86M
Income tax expense
2.66M
-6.27M
836.49K
-4.83M
Effective tax rate
9.55%
37.22%
4.26%
-502.11%
Other operating expenses
301.57K
1.24M
-2.65M
5.85M
Net income
25.18M
-10.57M
18.78M
5.79M
Net profit margin
12.06%
-5.49%
10.18%
2.91%
Earnings per share
-
-
-
-
Interest and investment income
6.16M
5.57M
-
8.88M
Interest expense
-2.98M
-2.95M
-2.33M
-2.63M
Net interest expenses
3.17M
2.61M
-2.33M
6.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
83.08M
-19.08M
55.82M
35.63M
Gain or loss from assets sale
-194.30K
767.63K
-
63.55K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps